Abstract
To appreciate the full benefits of treatment for lung cancer, especially in trials that fail to show improvements in survival, data recording the quality of life must be captured and refined to produce meaningful information. A conceptual model for quality of life for lung cancer patients was tested to obtain information about the dimensions of the quality-of-life construct for ongoing development and testing of a subjective measure for clinical trials. Using a longitudinal study design, the stability of predictive factors of the physical and functional dimensions of quality of life were examined using regression analysis. A patient-rated quality-of-life measure, the Lung Cancer Symptom Scale (LCSS), was administered to 144 non-smallcell lung cancer patients at baseline, day 29, and day 71 of a chemotherapy trial. The range of explained variance for all three components of the lung cancer model over three assessment points was as follows: symptomatic distress 41%–53%, activity status 48%–52%, and overall quality of life 35%–53%. The three dimensions fluctuated slightly during intervention, but were relatively stable factors across all three times of evaluation. The LCSS model explained nearly half of the variance for quality of life experienced by lung cancer patients during therapy with a new chemotherapeutic agent. These findings provide support that the physical and functional dimensions are important predictors of quality of life for individuals with lung cancer. Meaningful subjective quality-of-life data can be obtained to evaluate an intervention by using a disease-and sitespecific quality-of-life measure for individuals with lung cancer, based on a reproducible conceptual model such as the LCSS, which is suitable for serial measurement for the progressive disease of lung cancer.
Similar content being viewed by others
References
Aaronson NK (1991) Methodological issues in assessing the quality of life of cancer patients. Cancer 67:844–850
Aaronson NK, Meyerowitz BE, Bard M, et al (1991) Quality of life research in oncology: past achievements and future priorities. Cancer 67:839–843
Bakker W, Van Oosterom AT, Aaronson NK, et al (1986) Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life. Eur J Cancer Clin Oncol 22:963–970
Burke MT, Gralla R, Kris M, et al (1985) Subjective evaluation in non-small cell lung cancer: comparison of Karnofsky performance status with a patient generated visual analogue scale measuring activity. In: Proceedings of the IVth World Conference on Lung Cancer, vol 4, p 42
Carmines EG, Zeller RA (1979) Reliability and validity assessment. Sage, Beverly Hills, Calif
Cassileth BR, Lusk EJ, Brown LL, et al (1985) Psychosocial status of cancer patients and next of kin: normative data from the Profile of Mood States. J Psychosoc Oncol 3:99–105
Cella DF (1991) Functional status and quality of life: current views on measurement and intervention. In: Functional status and quality of life in persons with cancer. Selected papers from the First National Conference on Cancer Nursing Research. American Cancer Society, Atlanta, Ga, pp 1–12
Cella DF, Tross S, Orav EJ, et al (1989) Mood states of patients after the diagnosis of cancer. J Psychosoc Oncol 7:45–54
Chang AY, Kim K, Glick J, et al (1993) Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388–394
Deyo RA, Patrick DL (1989) Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 27:S254-S268
Dirksen SR (1990) Theoretical modeling to predict subjective well-being. West J Nurs Res 12:629–643
Feinstein AR (1977) Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmacol Ther 22:485–498
Feld R (1989) Quality of life assessment in patients with carcinoma of the lung. Chest 96:105S-107S
Fergusson RJ, Cull A (1991) Quality of life measurement for patients undergoing treatment for lung cancer. Thorax 46:671–675
Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17 [Suppl]:15–19
Ferrell B, Grant M, Schmidt GM, et al (1992) The meaning of quality of life for bone marrow transplant survivors. Part I. The impact of bone marrow transplant on quality of life. Cancer Nurs 15:153–160
Fries JF (1991) The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. Controlled Clin Trials 12:106S-117S
Graham KY, Longman AJ (1987) Quality of life and persons with melanoma. Cancer Nurs 10:338–346
Gralla R, Kris M (1988) Chemotherapy in non-small cell lung cancer: results of recent trials. Semin Oncol 15:2–5
Gralla R, Casper ES, Kelsen DP, et al (1981) Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigation two dosage schedules. Ann Intern Med 95:414–420
Green N, Kurohara SS, George FW (1971) Cancer of the lung: an indepth analysis of prognostic factors. Cancer 28:1229–1233
Hollen PJ, Kris M, Gralla R, et al (1993) Measurement of quality of life in lung cancer patients on multicenter trials of new therapies: psychometric properties of the Lung Cancer Symptom Scale (LCSS). Proc Am Soc Clin Oncol 12:463
Hollen PJ, Gralla R, Kris M, et al (1993) Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A:S51-S58
Holmes S, Dickerson J (1987) The quality of life: design and evaluation of a self-assessment instrument for use with cancer patients. Int J Nurs Stud 24:15–24
Hughes JE (1985) Depressive illness and lung cancer. II. Follow-up of inoperable patients. Eur J Surg Oncol 11:21–24
Lanzotti VJ, Thomas DR, Boyle LE, et al (1977) Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria. Cancer 39:303–313
Maas A (1991) A model for quality of life after laryngectomy. Soc Sci Med 33:1373–1377
McCullagh P, Nelder JA (1989) Generalized linear models, 2nd edn. Chapman & Hall, London
Miller AB, Hoogstraten B, Staquet M, et al (1981) Reporting results of cancer treatment. Cancer 47:207–214
Monras P, Gralla R, Burke MT, et al (1985) Development of specific instruments for subjective evaluation of patients with lung cancer: comparison of observer assessment with patient generated visual analogue scales (VAS). Proc Am Soc Clin Oncol 4:251
Mor V (1987) Cancer patients' quality of life over the disease course: lessons from the real world. J Chronic Dis 40:535–544
Mor V, Laliberte L, Morris JN, et al (1984) The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer 53:2002–2007
Munkres A, Oberst MT, Hughes SH (1992) Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer. Oncol Nurs Forum 19:1201–1209
Murphy WK, Fossella FV, Winn RJ, et al (1993) Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 85:384–388
O'Connell JP, Kris M, Gralla R, et al (1985) Analysis of factors predicting outcome in 350 patients with stage III non-small cell lung cancer (NSCLC) receiving high-dose cisplatin/Vinca alkaloid regimens. Proc Am Soc Clin Oncol 4:190
O'Connell JP, Kris M, Gralla R, et al (1986) Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol 4:1604–1614
Osoba D (1991) Measuring the effect of cancer on quality of life. In: Osoba D (ed) Effect of cancer on quality of life. CRC Press, Boca Raton, Fla, pp 25–40
Padilla GV, Grant MM (1985) Quality of life as a cancer nursing outcome variable. Adv Nurs Sci 8:45–60
Polit DF, Hungler BP (1991) Nursing research: principles and methods, 4th edn. Lippincott, Philadelphia
Sarna L (1991) Impact of chemotherapy on disruptions in quality of life and functional status of older adults with non-small cell lung cancer. In: Functional status and quality of life in persons with cancer. Selected papers from the First National Conference on Cancer Nursing Research. American Cancer Society, Atlanta, Ga, pp 13–26
Stewart AL, Ware JE, Brook RH (1981) Advances in the measurement of functional status: construction of aggregate indexes. Med Care 19:473–488
Ware JE (1984) Conceptualizing disease impact and treatment outcomes. Cancer 53 [Suppl]:2316–2323
Zhan L (1992) Quality of life: conceptual and measurement issues. J Adv Nurs 17:795–800
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hollen, P.J., Gralla, R.J., Kris, M.G. et al. Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2, 213–222 (1994). https://doi.org/10.1007/BF00365725
Issue Date:
DOI: https://doi.org/10.1007/BF00365725